Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (47)

2024

  1. Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

    Cancers, Vol. 16, Núm. 7

  2. DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review

    Clinical Epigenetics, Vol. 16, Núm. 1

  3. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  4. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

  5. Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer

    Molecular and Cellular Proteomics, Vol. 23, Núm. 10

  6. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis

    Diagnostics, Vol. 14, Núm. 14

2023

  1. Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study

    ERJ Open Research, Vol. 9, Núm. 6

  2. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

  3. Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 3, pp. 1046-1055

  4. Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment

    Biomaterials Science, Vol. 11, Núm. 12, pp. 4210-4225

  5. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

    Frontiers in Cell and Developmental Biology, Vol. 11

  6. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

    Biomaterials Science

  7. Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers

    Frontiers in Immunology, Vol. 14

  8. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer

    Japanese Dental Science Review, Vol. 59, pp. 289-302

  9. MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles

    iScience, Vol. 26, Núm. 3

  10. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  11. NAD pool as an antitumor target against cancer stem cells in head and neck cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 42, Núm. 1

  12. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

  13. PEGylation Effects on the Interaction of Sphingomyelin Nanoemulsions with Serum Albumin: A Thermodynamic Investigation

    Macromolecular Materials and Engineering, Vol. 308, Núm. 6

  14. Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

    Journal of Controlled Release, Vol. 356, pp. 702-713